MOBVEC will be the first VBD Mobile Bio-Lab in the world, providing a global service:
1- Automatic information about vector populations and environment, obtained in real-time by smart-traps, powered by machine-learning and edge computing: insect species, sex, age, and viral infection.
2- GEOSS compliant vector risk maps of adult insects and eggs/larvae, built on field + Copernicus data;
3- GEOSS compliant disease transmission models in mosquito population, fusing data provided by a) Copernicus, b) clinical and diagnostic data of reference labs, and c) vector risk maps;
4- GEOSS compliant citizen-science platform to reinforce the surveillance of mosquitoes using citizens as observation nodes, whose data is automatically calibrated using the data from smart traps.
5- VBD mobile bio-lab with the capacities of points 1, 2 and 3 + VBD Epidemiological maps, forecast models, and molecular analysis of arboviruses, to be rapidly operational in the heart of VBD outbreaks to assist first-responders
The main impact is to save lives and reduce the risk of vector-borne diseases as almost 1 million people die from VBDs every year, and hundreds of millions experience pain and suffering.
Economic Impacts:
-Reduce costs of vector surveillance;
-Reduction of costs of medical assistance to populations infected by vector-borne diseases;
-Reduction of costs associated with lost working hours due to cases of infection
Social Impacts:
-Protect populations in urban and rural areas, reducing the burden of the diseases carried by mosquitoes;
-Business opportunities for SMEs and support employment with the manufacture and distribution of MOBVEC assets.
-Creation of new IPM services and jobs in all regions at risk
Advancement of science and technology Impacts:
-Improve on-site detection, diagnostic and metagenomics knowledge of vector species;
-Better understand mosquito dynamics, infestations, eradication and surveillance practices;
-Consolidate transnational knowledge on regions affected by mosquitoes;
-Screen specific problems related to technology use, best practices and development of IPM procedures.
Environmental/Health Impacts:
-Sustainable use of insecticides ensuring a high level of environmental and human health protection;
-Prevent the increasing endemicity of diseases like Dengue, West Nile, Zika, Chikungunya, etc.;
-Support the WHO and Health Protection Agencies with less resources and public costs;
-Contribute to climate change counter actions and citizen resilience using citizen-science.
